Article
Cataract patients tolerate tobramycin and dexamethasone suspension four times daily
Barcelona, Spain-A combination eye-drop formulation of tobramycin and dexamethasone suspension (TobraDex, Alcon) is safe and well tolerated in patients when administered four times daily to control inflammation following cataract surgery.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
